Pacific Biosciences Of California (PACB) Receivables - Other (2011 - 2013)

Pacific Biosciences Of California's Receivables - Other history runs 3 years deep, the most recent figure standing at $3000.0 for Q4 2013.

• On a quarterly basis, Receivables - Other fell 99.63% year-over-year to $3000.0 in Q4 2013; TTM through Dec 2013 was $3000.0, a 99.63% decrease from a year earlier, with the FY2013 full-year figure at $3000.0, down 99.63% from the prior year.
• Receivables - Other retreated to $3000.0 in Q4 2013 per PACB's latest filing, from $814000.0 in the prior quarter.
• Across five years, Receivables - Other topped out at $814000.0 in Q4 2012 and bottomed at $3000.0 in Q4 2013.
• The 3-year median for Receivables - Other is $17000.0 (2011), against an average of $278000.0.
• Across the five-year window, Receivables - Other surged 4688.24% in 2012 and sank 99.63% in 2013, its largest moves.
• Year by year, Receivables - Other stood at $17000.0 in 2011, then jumped by 4688.24% to $814000.0 in 2012, then sank by 99.63% to $3000.0 in 2013.
• Per Business Quant, the three latest PACB Receivables - Other figures stand at $3000.0 (Q4 2013), $814000.0 (Q4 2012), and $17000.0 (Q4 2011).